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Ferredoxin-NADP+ oxidoreductase encoded by Bacillus subtilis yumC has been
puriﬁed and successfully crystallized in complex with NADP+ in two forms.
Diffraction data from crystals of these two forms were collected at resolutions of
1.8 and 1.9 A˚. The former belonged to space group P21212, with unit-cell
parameters a = 63.90, b = 135.72, c = 39.19 A˚, and the latter to space group C2,
with unit-cell parameters a = 207.47, b = 64.85, c = 61.12 A˚,  = 105.82. The
initial structure was determined by the molecular-replacement method using a
thioredoxin reductase-like protein as a search model.
1. Introduction
Ferredoxin-NADP+ oxidoreductases (FNRs) are ubiquitous ﬂavo-
enzymes that contain a noncovalently bound FAD. FNRmediates the
redox reaction between NADP+/NADPH and ferredoxin, providing
redox equivalents in cell-material synthesis (Knaff & Hirasawa, 1991;
Ceccarelli et al., 2004; Aliverti et al., 2008). On the basis of phylo-
genetic and structural analyses, FNRs have been classiﬁed into two
groups: plastid-type and glutathione reductase-type FNRs (Aliverti et
al., 2008). Both types exist as monomeric proteins composed of two
nucleotide-binding domains, one for FAD binding and the other for
NAD(P)H binding. Recently, it has been reported that a novel type of
FNR has been obtained from several bacteria (Seo & Sakurai, 2002;
Seo et al., 2004; Mandai et al., 2009). These FNRs occur as homo-
dimers and share a higher level of amino-acid sequence homology
with thioredoxin reductases (Waksman et al., 1994) than with the two
groups of FNRs mentioned above. BLAST searches (Altschul et al.,
1997) showed that a number of genes homologous to this novel FNR
are present in some Gram-positive bacteria and archaea that have no
gene coding for a protein with a high sequence identity to the known
FNRs. This novel FNR constitutes a new group of FNRs in addition
to the previously established plastid-type and glutathione reductase-
type FNRs. In order to obtain the structure of this novel FNR from
Bacillus subtilis (BsFNR), we performed its crystallization and
preliminary X-ray analysis.
2. Materials and methods
2.1. Protein purification and crystallization
Expression and puriﬁcation of BsFNR were carried out according
to previously described methods (Seo et al., 2009). Puriﬁed BsFNR
was concentrated to 10 mg ml1 in 50 mM Tris–HCl pH 8.0 buffer
containing 200 mM NaCl. The concentration of BsFNR was deter-
mined using a molar absorption coefﬁcient of 12 300M1 cm1 at
457 nm. For crystallization of the BsFNR–NADP+ complex, 2.5 mM
NADP+ was added to the BsFNR solution. Crystallization screening
was carried out using Crystal Screens I and II and PEG/Ion Screen
from Hampton Research and the Cryo I and II sparse-matrix crys-
tallization screens from Emerald BioSystems with the sitting-drop
vapour-diffusion method at 293 K. Protein droplets prepared by
mixing 1 ml protein solution and 1 ml reservoir solution were equili-
brated against 100 ml reservoir solution at 293 K.
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2.2. Dynamic light scattering
Solutions of 10 mg ml1 BsFNR and 2.5 mM NADP+ were utilized
for dynamic light-scattering (DLS) investigations. Debris in the
protein solution was removed by centrifugation (20 000g, 10 min)
before measurements. Automated measurements were carried out
with a Zetasizer V instrument (Malvern Instruments Ltd). A Peltier
thermostatting system was used to maintain the temperature at
298 K. Size distributions were acquired at regular time intervals for
BsFNR in 50 mM Tris–HCl buffer pH 8.0 containing 200 mM NaCl.
2.3. Data collection and crystallographic analysis
X-ray diffraction data sets were collected at 100 K on beamline
BL38B1 ( = 1.0000 A˚) at SPring-8 using a Rigaku Jupiter210 CCD
detector. The crystal-to-detector distance was maintained at 150 mm
with an oscillation range per image of 1.0, covering a total oscillation
range of 180. Determination of the unit-cell parameters and inte-
gration of reﬂections were performed using the HKL-2000 program
package (Otwinowski & Minor, 1997). Molecular replacement was
carried out using the program Phaser (McCoy et al., 2007). Further
reﬁnement and model building are in progress using the programs
REFMAC (Murshudov et al., 1997) and Coot (Emsley & Cowtan,
2004).
3. Results and discussion
The recombinant protein was puriﬁed to apparent homogeneity on
SDS–PAGE. Its molecular mass was approximately 40 kDa on SDS–
PAGE. The UV–Vis absorption spectra of the air-oxidized FNR
suggested that almost all protein molecules bound a ﬂavin. DLS was
used to assess the inﬂuence of NADP+ on the oligomerization of
BsFNR. The deduced diameters of BsFNR without and with NADP+
were 3.94 0.66 and 3.90 1.45 nm, respectively. The hydrodynamic
radius of BsFNR was not signiﬁcantly affected by the addition of
NADP+. The estimated molecular weight of about 80 000 indicated
dimer formation. We ﬁrst tried to crystallize BsFNR without NADP+
by extensive screening; needle-like crystals were obtained using
polyethylene glycol 3350 (PEG 3350) as precipitant (Fig. 1). How-
ever, the crystals diffracted to a resolution of approximately 10 A˚ and
were not suitable for further crystallographic analysis. Therefore, we
attempted the crystallization of BsFNR in complex with NADP+ and
obtained crystals with different shapes (forms I and II). The crys-
tallization conditions of the BsFNR–NADP+ complex were reﬁned
and two different crystal forms were obtained using reservoir solu-
tions consisting of 0.1M HEPES buffer pH 7.5, 30% 1,2-propanediol,
20% PEG 400 (form I) and 20% PEG 3350, 0.2M sodium ﬂuoride
and 5% trehalose (form II) (Fig. 1). For data collection, a form I
crystal was transferred directly from the mother liquor to a nitrogen
cold stream at 100 K. A form II crystal was soaked in a cryoprotectant
solution (25% PEG 3350, 0.2M sodium ﬂuoride and 15% trehalose)
for a few minutes prior to freezing in the nitrogen cold stream. The
diffraction of the form I and II crystals of the NADP+ complex
extended to 1.8 and 1.9 A˚ resolution, respectively. The form I crystal
belonged to space group P21212, with unit-cell parameters a = 63.90,
b = 135.72, c = 39.19 A˚. The form II crystal belonged to space group
C2, with unit-cell parameters a = 207.47, b = 64.85, c = 61.12 A˚,
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Figure 1
Crystals of B. subtilis FNR. (a) NADP+-free crystals. (b) Form I crystals of the
NADP+ complex. (c) Form II crystals of the NADP+ complex.
Table 1
Summary of crystallographic data.
Form I Form II
Space group P21212 C2
Unit-cell parameters (A˚, ) a = 63.90, b = 135.72,
c = 39.19
a = 207.47, b = 64.85,
c = 61.12,  = 105.82
Resolution (A˚) 50.00–1.80 (1.86–1.80) 50.00–1.90 (1.97–1.90)
No. of unique reﬂections 32363 59771
Multiplicity 7.0 (6.1) 3.6 (3.0)
Completeness (%) 99.9 (99.5) 96.9 (80.4)
hI/(I)i 23.0 (2.8) 22.6 (3.1)
Rmerge (%) 7.1 (38.8) 5.1 (22.0)
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 = 105.82. The calculated Matthews coefﬁcients (VM) of 2.12 and
2.47 A˚3 Da1 for forms I and II correspond to solvent contents of 42.1
and 50.3% assuming the presence of one and two protomers in the
asymmetric unit, respectively, and a protein molecular weight of
40 000 (Matthews, 1968). The data-collection statistics are summar-
ized in Table 1. Structure determination was performed by the
molecular-replacement method using the structure of the thioredoxin
reductase-like protein from Thermus thermophilus HB8 (PDB
code 2zbw; A. Ebihara, M. Manzoku, Y. Fujimoto, Y. Kitamura, S.
Yokoyama & S. Kuramitsu, unpublished work) as a search model
(45% sequence identity). The X-ray diffraction data used to solve the
BsFNR structure were collected from a form I crystal. Thioredoxin
reductase consists of two globular domains (the FAD-binding and
NADPH-binding domains) connected by a two-stranded -sheet
(Waksman et al., 1994). Thioredoxin reductase has been proposed to
undergo a conformational change on binding NADPH, leading to a
rotation of the two domains by around 60 relative to each other
(Lennon et al., 2000). BsFNR should also consist of two domains
connected by a ﬂexible linker. In order to allow conformational
ﬂexibility of the two domains, the search model was divided into two
parts (the FAD-binding and NADPH-binding domains). Molecular
replacement and consequent structure reﬁnement are now in
progress.
We thank the staff at beamline BL38B1, SPring-8, Japan. This
study was partly supported by the GCOE Program (YH), the Japa-
nese Aerospace Exploration Agency Project (YH), the Sumitomo
Foundation (HK), the Hyogo Science and Technology Association
(HK) and Grants-in-Aid for Scientiﬁc Research (18GS0207; YH) and
for Young Scientists B (HK) from the Japan Society for the Promo-
tion of Science.
References
Aliverti, A., Pandini, V., Pennati, A., de Rosa, M. & Zanetti, G. (2008). Arch.
Biochem. Biophys. 474, 283–291.
Altschul, S. F., Madden, T. L., Scha¨ffer, A. A., Zhang, J., Miller, W. & Lipman,
D. J. (1997). Nucleic Acids Res. 25, 3389–3402.
Ceccarelli, E. A., Arakai, A. K., Cortez, N. & Carrill, N. (2004). Biochim.
Biophys. Acta, 1698, 155–165.
Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126–2132.
Knaff, D. B. & Hirasawa, M. (1991). Biochim. Biophys. Acta, 1056, 93–125.
Lennon, B. W., Williams, C. H. Jr & Ludwig, M. L. (2000). Science, 289, 1190–
1194.
Mandai, T., Fujiwara, S. & Inaoka, S. (2009). FEBS J. 276, 2416–2429.
Matthews, B. W. (1968). J. Biol. Chem. 33, 491–497.
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni,
L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674.
Murshudov, G. N., Vagin, A. A. & Dodson, E. J. (1997). Acta Cryst. D53,
240–255.
Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326.
Seo, D., Kamino, K., Inoue, K. & Sakurai, H. (2004). Arch. Microbiol. 182,
80–89.
Seo, D., Okabe, S., Yanase, M., Kataoka, K. & Sakurai, T. (2009). Biochim.
Biophys. Acta, 1794, 594–601.
Seo, D. & Sakurai, H. (2002). Biochim. Biophys. Acta, 1597, 123–132.
Waksman, G., Krishna, T. S., Williams, C. H. Jr & Kuriyan, J. (1994). J. Mol.
Biol. 236, 800–816.
crystallization communications
Acta Cryst. (2010). F66, 301–303 Komori et al.  Ferredoxin-NADP+ oxidoreductase 303
electronic reprint
